• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate (CAS No. 61453-49-4): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate, identified by its unique Chemical Abstracts Service (CAS) number 61453-49-4, is a significant compound in the realm of pharmaceutical chemistry. This heterocyclic ester has garnered considerable attention due to its structural versatility and its role as a crucial intermediate in the synthesis of various biologically active molecules. The compound’s pyrazole core, flanked by ester and hydroxymethyl functional groups, provides a robust scaffold for further chemical modifications, making it an invaluable tool in medicinal chemistry.

The pyrazole moiety is a privileged scaffold in drug discovery, known for its ability to interact with biological targets across multiple therapeutic areas. Its five-membered ring structure, incorporating two nitrogen atoms, allows for diverse pharmacophoric arrangements, contributing to its widespread use in the development of pharmaceuticals. In particular, ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate has been explored in the synthesis of compounds with potential applications in anti-inflammatory, antiviral, and anticancer therapies.

Recent advancements in synthetic methodologies have highlighted the utility of this compound in constructing complex molecular architectures. The ester group at the 3-position and the hydroxymethyl group at the 4-position offer distinct handles for chemical transformations. For instance, nucleophilic acyl substitution reactions can be employed to introduce various amine or alcohol functionalities, while reduction or oxidation strategies can modify the hydroxymethyl or ester moieties, respectively. These modifications have enabled the generation of novel derivatives with tailored biological activities.

In the context of drug development, ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate has been utilized as a precursor in the synthesis of small-molecule inhibitors targeting enzyme-catalyzed processes. Pyrazole-based inhibitors have shown promise in disrupting key metabolic pathways involved in diseases such as diabetes and cancer. For example, derivatives of this compound have been investigated for their ability to inhibit polyphenol oxidase enzymes, which play a role in fruit ripening and food spoilage but are also implicated in certain pathological conditions.

The hydroxymethyl group serves as a versatile site for further functionalization, allowing for the attachment of pharmacophoric elements through etherification or amidation reactions. This flexibility has been exploited in designing molecules that exhibit enhanced solubility or targeted delivery properties. Additionally, the ester functionality can be hydrolyzed under acidic or basic conditions to yield corresponding carboxylic acids, which may be further derivatized into amides or salts for improved pharmacokinetic profiles.

Recent studies have also explored the use of ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate in combinatorial chemistry libraries. By systematically varying substituents on the pyrazole ring or introducing different protecting groups on the ester and hydroxymethyl functionalities, researchers can generate diverse libraries of compounds for high-throughput screening. This approach has accelerated the discovery of lead candidates with optimized binding affinities and selectivities against therapeutic targets.

The compound’s stability under various reaction conditions makes it a reliable building block for multi-step syntheses. It can be easily handled and stored without significant degradation, ensuring consistency in experimental outcomes. Furthermore, its compatibility with a range of solvents and reagents enhances its utility in industrial-scale production processes.

From a computational chemistry perspective, ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate has been subjected to molecular modeling studies to understand its interactions with biological targets. These studies have provided insights into how structural modifications can influence binding affinity and selectivity. For instance, virtual screening techniques have been employed to identify potential binding pockets on proteins where pyrazole-based molecules can dock effectively.

The growing interest in green chemistry has also prompted investigations into sustainable synthetic routes for ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate. Catalytic methods that minimize waste and reduce energy consumption are being explored to enhance environmental compatibility. Such efforts align with global initiatives to promote sustainable pharmaceutical manufacturing practices.

In conclusion,Ethyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate (CAS No. 61453-49-4) represents a valuable intermediate with broad applications in pharmaceutical synthesis. Its structural features enable diverse chemical modifications, making it a versatile building block for developing novel therapeutics. As research continues to uncover new synthetic strategies and biological applications,this compound is poised to remain a cornerstone in medicinal chemistry endeavors.

• 33090-46-9(4,5-dimethyl 1H-pyrazole-4,5-dicarboxylate)
• 6076-12-6(Ethyl 4-methyl-1H-pyrazole-5-carboxylate)
• 318497-88-0(Ethyl 4-cyano-1H-pyrazole-5-carboxylate)
• 179692-09-2(Ethyl 4-formyl-1H-pyrazole-3-carboxylate)
• 61453-47-2(1H-Pyrazole-3-carboxylic acid, 4-[(acetyloxy)methyl]-, methyl ester)
• 124598-39-6(methyl 4-(hydroxymethyl)-1H-pyrazole-3-carboxylate)
• 856061-38-6(Ethyl 4-methyl-1H-pyrazole-5-carboxylate)
• 60858-33-5(1H-Pyrazole-3-carboxylic acid, 4,5-dimethyl-, methyl ester)
• 68809-58-5(methyl 4-methyl-1H-pyrazole-3-carboxylate)
• 60659-21-4(1H-Pyrazole-3-carboxylic acid, 4-[(acetyloxy)methyl]-, ethyl ester)